Enzyme-responsive mesoporous silica nanoparticles for tumor cells and mitochondria multistage-targeted drug delivery

References

• Battogtokh G, Gotov O, Kang JH, et al. Triphenylphosphine-docetaxel conjugate-incorporated albumin nanoparticles for cancer treatment. Nanomedicine. 2018;13(3):325–338. doi:10.2217/nnm-2017-027429338573
   PubMed Web of Science ®Google Scholar
• Youn YS, Bae YH. Perspectives on the past, present, and future of cancer nanomedicine. Adv Drug Delivery Rev. 2018;130:3–11. doi:10.1016/j.addr.2018.05.008
   PubMed Web of Science ®Google Scholar
• Shi J, Kantoff PW, Wooster R, Farokhzad OC. Cancer nanomedicine: progress, challenges and opportunities. Nat Rev Cancer. 2017;17(1):20–37. doi:10.1038/nrc.2016.10827834398
   PubMed Web of Science ®Google Scholar
• Chen G, Xie Y, Peltier R, et al. Peptide-decorated gold nanoparticles as functional nano-capping agent of mesoporous silica container for targeting drug delivery. ACS Appl Mater Interfaces. 2016;8(18):11204–11209. doi:10.1021/acsami.6b0259427102225
   PubMed Web of Science ®Google Scholar
• Dong D-W, Xiang B, Gao W, Yang -Z-Z, Li J-Q, Qi X-R. pH-responsive complexes using prefunctionalized polymers for synchronous delivery of doxorubicin and siRNA to cancer cells. Biomaterials. 2013;34(20):4849–4859. doi:10.1016/j.biomaterials.2013.03.01823541420
   PubMedGoogle Scholar
• Wicki A, Witzigmann D, Balasubramanian V, Huwyler J. Nanomedicine in cancer therapy: challenges, opportunities, and clinical applications. J Control Release. 2015;200:138–157. doi:10.1016/j.jconrel.2014.12.03025545217
   PubMed Web of Science ®Google Scholar
• Bhaskara RM, Linker SM, Voegele M, Koefinger J, Hummer G. Carbon nanotubes mediate fusion of lipid vesicles. ACS Nano. 2017;11(2):1273–1280. doi:10.1021/acsnano.6b0543428103440
   PubMedGoogle Scholar
• Feng S, Zhang H, Yan T, et al. Folate-conjugated boron nitride nanospheres for targeted delivery of anticancer drugs. Int J Nanomedicine. 2016;11:4573–4582. doi:10.2147/IJN.S11068927695318
   PubMedGoogle Scholar
• Feng S, Zhang H, Zhi C, Gao X-D, Nakanishi H. pH-responsive charge-reversal polymer-functionalized boron nitride nanospheres for intracellular doxorubicin delivery. Int J Nanomedicine. 2018;13:641–652. doi:10.2147/IJN.S15347629440891
   PubMed Web of Science ®Google Scholar
• Merino S, Martin C, Kostarelos K, Prato M, Vazquez E. Nanocomposite hydrogels: 3D polymer-nanoparticle synergies for on-demand drug delivery. ACS Nano. 2015;9(5):4686–4697. doi:10.1021/acsnano.5b0143325938172
   PubMed Web of Science ®Google Scholar
• Pattni BS, Chupin VV, Torchilin VP. New developments in liposomal drug delivery. Chem Rev. 2015;115(19):10938–10966. doi:10.1021/acs.chemrev.5b0004626010257
   PubMed Web of Science ®Google Scholar
• Ulbrich K, Hola K, Subr V, Bakandritsos A, Tucek J, Zboril R. Targeted drug delivery with polymers and magnetic nanoparticles: covalent and noncovalent approaches, release control, and clinical studies. Chem Rev. 2016;116(9):5338–5431. doi:10.1021/acs.chemrev.5b0058927109701
   PubMed Web of Science ®Google Scholar
• Yao X, Niu X, Ma K, et al. Graphene quantum dots-capped magnetic mesoporous silica nanoparticles as a multifunctional platform for controlled drug delivery, magnetic hyperthermia, and photothermal therapy. Small. 2017;13(2). doi:10.1002/smll.201602225.
   Web of Science ®Google Scholar
• Yu X, Zhu Y. Preparation of magnetic mesoporous silica nanoparticles as a multifunctional platform for potential drug delivery and hyperthermia. Sci Technol Adv Mat. 2016;17(1):229–238. doi:10.1080/14686996.2016.1178055
   PubMed Web of Science ®Google Scholar
• Chen C, Sun W, Wang X, Wang Y, Wang P. pH-responsive nanoreservoirs based on hyaluronic acid end-capped mesoporous silica nanoparticles for targeted drug delivery. Int J Biol Macromol. 2018;111:1106–1115. doi:10.1016/j.ijbiomac.2018.01.09329357289
   PubMed Web of Science ®Google Scholar
• Huang L, Liu J, Gao F, et al. A dual-responsive, hyaluronic acid targeted drug delivery system based on hollow mesoporous silica nanoparticles for cancer therapy. J Mater Chem B. 2018;6(28):4618–4629. doi:10.1039/C8TB00989A
   PubMed Web of Science ®Google Scholar
• Tao C, Zhu Y. Magnetic mesoporous silica nanoparticles for potential delivery of chemotherapeutic drugs and hyperthermia. Dalton Trans. 2014;43(41):15482–15490. doi:10.1039/c4dt01984a25190592
   PubMedGoogle Scholar
• Tian Z, Yu X, Ruan Z, Zhu M, Zhu Y, Hanagata N. Magnetic mesoporous silica nanoparticles coated with thermo-responsive copolymer for potential chemo- and magnetic hyperthermia therapy. Microporous Mesoporous Mater. 2018;256:1–9. doi:10.1016/j.micromeso.2017.07.053
   Web of Science ®Google Scholar
• de la Torre C, Agostini A, Mondragon L, et al. Temperature-controlled release by changes in the secondary structure of peptides anchored onto mesoporous silica supports. Chem Commun. 2014;50(24):3184–3186. doi:10.1039/C3CC49421G
   PubMed Web of Science ®Google Scholar
• Qiao L, Wang X, Gao Y, et al. Laccase-mediated formation of mesoporous silica nanoparticle based redox stimuli-responsive hybrid nanogels as a multifunctional nanotheranostic agent. Nanoscale. 2016;8(39):17241–17249. doi:10.1039/c6nr05943k27722385
   PubMedGoogle Scholar
• Sun Y-L, Zhou Y, Li Q-L, Yang Y-W. Enzyme-responsive supramolecular nanovalves crafted by mesoporous silica nanoparticles and choline-sulfonatocalix 4 arene 2 pseudorotaxanes for controlled cargo release. Chem Commun. 2013;49(79):9033–9035. doi:10.1039/c3cc45216f
   PubMed Web of Science ®Google Scholar
• Zeng X, Liu G, Tao W, et al. A drug-self-gated mesoporous antitumor nanoplatform based on pH-sensitive dynamic covalent bond. Adv Funct Mater. 2017;27(11):1605985.
   Web of Science ®Google Scholar
• Zhang Q, Liu F, Kim Truc N, et al. Multifunctional mesoporous silica nanoparticles for cancer-targeted and controlled drug delivery. Adv Funct Mater. 2012;22(24):5144–5156. doi:10.1002/adfm.201201316
   Web of Science ®Google Scholar
• Cheng W, Nie J, Xu L, et al. pH-sensitive delivery vehicle based on folic acid-conjugated polydopamine-modified mesoporous silica nanoparticles for targeted cancer therapy. ACS Appl Mater Interfaces. 2017;9(22):18462–18473. doi:10.1021/acsami.7b0245728497681
   PubMed Web of Science ®Google Scholar
• Oezalp VC, Schaefer T. Aptamer-based switchable nanovalves for stimuli-responsive drug delivery. Chem-Eur J. 2011;17(36):9893–9896. doi:10.1002/chem.20110140321796694
   PubMedGoogle Scholar
• Sun X, Luo Y, Huang L, Yu B-Y TJ. A peptide-decorated and curcumin-loaded mesoporous silica nanomedicine for effectively overcoming multidrug resistance in cancer cells. RSC Adv. 2017;7(27):16401–16409. doi:10.1039/C7RA01128H
   Web of Science ®Google Scholar
• Zhang Y, Guo J, Zhang X-L, et al. Antibody fragment-armed mesoporous silica nanoparticles for the targeted delivery of bevacizumab in ovarian cancer cells. Int J Pharm. 2015;496(2):1026–1033. doi:10.1016/j.ijpharm.2015.10.08026541303
   PubMedGoogle Scholar
• Chen Z, Li Z, Lin Y, Yin M, Ren J, Qu X. Bioresponsive hyaluronic acid-capped mesoporous silica nanoparticles for targeted drug delivery. Chem-Eur J. 2013;19(5):1778–1783. doi:10.1002/chem.20120203823303570
   PubMed Web of Science ®Google Scholar
• Liu DC, Pearlman E, Diaconu E, et al. Expression of hyaluronidase by tumor cells induces angiogenesis in vivo. Proc Natl Acad Sci U S A. 1996;93(15):7832–7837.8755562
   PubMed Web of Science ®Google Scholar
• Stern R, Jedrzejas MJ. Hyaluronidases: their genomics, structures, and mechanisms of action. Chem Rev. 2006;106(3):818–839. doi:10.1021/cr050247k16522010
   PubMed Web of Science ®Google Scholar
• Toole BP. Hyaluronan: from extracellular glue to pericellular cue. Nat Rev Cancer. 2004;4(7):528–539. doi:10.1038/nrc139115229478
   PubMed Web of Science ®Google Scholar
• Chamberlain GR, Tulumello DV, Kelley SO. Targeted delivery of doxorubicin to mitochondria. ACS Chem Biol. 2013;8(7):1389–1395. doi:10.1021/cb400095v23590228
   PubMed Web of Science ®Google Scholar
• Xi J, Li M, Jing B, et al. Long-circulating amphiphilic doxorubicin for tumor mitochondria-specific targeting. ACS Appl Mater Interfaces. 2018;10:43482–43492. doi:10.1021/acsami.8b1739930479120
   PubMed Web of Science ®Google Scholar
• Marrache S, Dhar S. Engineering of blended nanoparticle platform for delivery of mitochondria-acting therapeutics. Proc Natl Acad Sci U S A. 2012;109(40):16288–16293. doi:10.1073/pnas.121009610922991470
   PubMed Web of Science ®Google Scholar
• Chakrabortty S, Agrawalla BK, Stumper A, et al. Mitochondria targeted protein-ruthenium photosensitizer for efficient photodynamic applications. J Am Chem Soc. 2017;139(6):2512–2519. doi:10.1021/jacs.6b1339928097863
   PubMedGoogle Scholar
• Smith RAJ, Porteous CM, Gane AM, Murphy MP. Delivery of bioactive molecules to mitochondria in vivo. Proc Natl Acad Sci U S A. 2003;100(9):5407–5412. doi:10.1073/pnas.093124510012697897
   PubMed Web of Science ®Google Scholar
• Zhang X, Yan Q, Mulatihan DN, et al. Pharmaceutical micelles featured with singlet oxygen-responsive cargo release and mitochondrial targeting for enhanced photodynamic therapy. Nanotechnology. 2018;29(25):255101. doi:10.1088/1361-6528/aabbdb29620538
   PubMedGoogle Scholar
• Lv X, Zhang L, Xing F, Lin H. Controlled synthesis of monodispersed mesoporous silica nanoparticles: particle size tuning and formation mechanism investigation. Microporous Mesoporous Mater. 2016;225:238–244. doi:10.1016/j.micromeso.2015.12.024
   Web of Science ®Google Scholar
• Nairi V, Magnolia S, Piludu M, et al. Mesoporous silica nanoparticles functionalized with hyaluronic acid. Effect of the biopolymer chain length on cell internalization. Colloids Surf B. 2018;168:50–59. doi:10.1016/j.colsurfb.2018.02.019
   PubMed Web of Science ®Google Scholar
• Xu Y, Claiden P, Zhu Y, Morita H, Hanagata N. Effect of amino groups of mesoporous silica nanoparticles on CpG oligodexynucleotide delivery. Sci Technol Adv Mat. 2015;16(4):045006. doi:10.1088/1468-6996/16/4/045006
   PubMed Web of Science ®Google Scholar
• Li S-D, Huang L. Pharmacokinetics and biodistribution of nanoparticles. Mol Pharm. 2008;5(4):496–504. doi:10.1021/mp800049w18611037
   PubMed Web of Science ®Google Scholar
• Zhou J, Hao N, De Zoyza T, Yan M, Ramstrom O. Lectin-gated, mesoporous, photofunctionalized glyconanoparticles for glutathione-responsive drug delivery. Chem Commun. 2015;51(48):9833–9836. doi:10.1039/C5CC02907D
   PubMed Web of Science ®Google Scholar
• Chen W-H, Luo G-F, Qiu W-X, et al. Mesoporous silica-based versatile theranostic nanoplatform constructed by layer-by-layer assembly for excellent photodynamic/chemo therapy. Biomaterials. 2017;117:54–65. doi:10.1016/j.biomaterials.2016.11.05727936417
   PubMed Web of Science ®Google Scholar
• Jiang H, Peterson RS, Wang WH, Bartnik E, Knudson CB, Knudson W. A requirement for the CD44 cytoplasmic domain for hyaluronan binding, pericellular matrix assembly, and receptor-mediated endocytosis in COS-7 cells. J Biol Chem. 2002;277(12):10531–10538. doi:10.1074/jbc.M10865420011792695
   PubMedGoogle Scholar